GL1X · GenesisL1 explorer

Research workbench

Vaccine-elicited nhp fp-targeting antibody DF2F-E.01 in complex with HIV fusion peptide (residue 512-519)

Analyse Vaccine-elicited nhp fp-targeting antibody DF2F-E.01 in complex with HIV fusion… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6PEC
Type
protein
Length
432 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Antibody light chain; Antibody heavy chain; HIV-1 fusion peptide residue 512-519
Pockets
2 · best druggability 0.55

Structure

x-ray diffraction · 3 distinct chains · 7% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LAntibody light chainprotein2085% helix, 50% strand—
HAntibody heavy chainprotein2167% helix, 54% strand—
AHIV-1 fusion peptide residue 512-519protein850% helix, 0% strand—

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13600.550.7446empty
2580.270.7417empty

Interfaces

3 interfaces between chains.

  • L–H · 1723 Ų buried · 17 hydrogen bonds · protein-protein
  • H–A · 368 Ų buried · 4 hydrogen bonds · protein-protein
  • L–A · 275 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 6PEC · Vaccine-elicited NHP FP-targeting antibody DF2F-e.01 in complex with HIV fusion peptide… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.